Exact Sciences Maintains Full-year 2024 Revenue Guidance Of $2.81B - $2.85B, Est $2.829B
Portfolio Pulse from Benzinga Newsdesk
Exact Sciences has maintained its full-year 2024 revenue guidance of $2.81B to $2.85B, aligning with estimates of $2.829B. The company has also raised its full-year adjusted EBITDA guidance midpoint by $8M.
July 31, 2024 | 8:27 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Exact Sciences has reaffirmed its full-year 2024 revenue guidance and raised its adjusted EBITDA guidance midpoint by $8M, indicating strong financial performance.
Maintaining revenue guidance and raising EBITDA guidance midpoint suggests strong financial health and operational efficiency, likely boosting investor confidence and positively impacting the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100